The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management? (Q35842504)

10 August 2017

1 reference

title

The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management? (English)

1 reference

10 August 2017

Carine Ali

3

0 references

Denis Vivien

object named as

Denis Vivien

series ordinal

2

0 references

Nathalie Lebeurrier

series ordinal

1

object named as

Nathalie Lebeurrier

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Expert Opinion on Therapeutic Targets

10 August 2017

published in

1 reference

10 August 2017

volume

8

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

309-320

1 reference

Incidence and characteristics of total stroke in the United States

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Mechanisms, challenges and opportunities in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Human cellular inflammation in the pathology of acute cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Antioxidant therapy in acute central nervous system injury: current state

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Treatment of acute ischemic stroke: Part I: recanalization strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Treatment of acute ischemic stroke: Part II: neuroprotection and medical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuroprotection for ischaemic stroke: an unattainable goal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

De novo neurogenesis and acute stroke: are exogenous stem cells really necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Enhanced neurogenesis following stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuronal replacement from endogenous precursors in the adult brain after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Combination therapy for ischemic stroke: potential of neuroprotectants plus thrombolytics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

The long-term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Unriddling the role of matrix metalloproteinases in human cerebral stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Extracellular proteolysis in the adult murine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuronal cell death and tPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Equivocal roles of tissue-type plasminogen activator in stroke-induced injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Development of thrombolytic therapy for stroke: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

LRP: a bright beacon at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Serpin structure, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Hemostatic factors as risk markers for intracerebral hemorrhage: a prospective incident case-referent study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Acyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Neuroserpin, a neuroprotective factor in focal ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Serpinopathies and the conformational dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

Tissue plasminogen activator as a key effector in neurobiology and neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.4.309

21 January 2018

Identifiers

DOI

10.1517/14728222.8.4.309

1 reference

10 August 2017

1 reference